VYNE - VYNE Therapeutics Inc
0.6
-0.002 -0.300%
Share volume: 172,098
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.60
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-07-2024 | 03-06-2025 | 05-08-2025 | 08-14-2025 | |
| Cash flow financing | -4.000 K | -3.000 K | -2.000 K | -132.000 K | -87.000 K | -34.000 K | |
| Other financing cash flows | 0.000 | -3.000 K | -2.000 K | -132.000 K | -87.000 K | -34.000 K | |
| Cash flow | -7.982 M | 10.536 M | -13.336 M | 3.607 M | 8.283 M | -6.162 M | |
| Net income | -6.249 M | -9.406 M | -12.157 M | -12.022 M | -8.611 M | -5.755 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 6.000 K | 6.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -3.569 M | 19.020 M | -4.824 M | 12.738 M | 19.831 M | 4.675 M | |
| Net Borrowings | -89.989 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 85.950 M | 10.536 M | -13.336 M | 3.607 M | 8.283 M | -6.162 M |